Styrenix Performance Materials Intrinsic Value

STYRENIX • Chemicals
Current Stock Price
₹1975.80
Primary Intrinsic Value
₹1220.64
Market Cap
₹3556 Cr
-41.3% Downside
Median Value
₹1159.47
Value Range
₹649 - ₹1426
Assessment
Trading Above Calculated Value
Safety Margin
-70.4%

STYRENIX Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1220.64 ₹976.51 - ₹1464.77 -38.2% EPS: ₹101.72, Sector P/E: 12x
Book Value Method asset ₹648.89 ₹584.00 - ₹713.78 -67.2% Book Value/Share: ₹648.89, P/B: 1.0x
Revenue Multiple Method revenue ₹1425.78 ₹1283.20 - ₹1568.36 -27.8% Revenue/Share: ₹1782.22, P/S: 0.8x
EBITDA Multiple Method earnings ₹1159.47 ₹1043.52 - ₹1275.42 -41.3% EBITDA: ₹352.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹790.32 ₹632.26 - ₹948.38 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹651.01 ₹585.91 - ₹716.11 -67.1% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹838.17 ₹754.35 - ₹921.99 -57.6% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹1400.00 ₹1260.00 - ₹1540.00 -29.1% ROE: 15.4%, P/E Multiple: 14x
Graham Defensive Method conservative ₹1218.65 ₹1096.79 - ₹1340.52 -38.3% EPS: ₹101.72, BVPS: ₹648.89
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check STYRENIX share price latest .

Valuation Comparison Chart

STYRENIX Intrinsic Value Analysis

What is the intrinsic value of STYRENIX?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Styrenix Performance Materials (STYRENIX) is ₹1159.47 (median value). With the current market price of ₹1975.80, this represents a -41.3% variance from our estimated fair value.

The valuation range spans from ₹648.89 to ₹1425.78, indicating ₹648.89 - ₹1425.78.

Is STYRENIX undervalued or overvalued?

Based on our multi-method analysis, Styrenix Performance Materials (STYRENIX) appears to be trading above calculated value by approximately 41.3%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.94 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.96 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 15.4% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 11.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.40x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹54 Cr ₹12 Cr Positive Free Cash Flow 7/10
March 2024 ₹216 Cr ₹172 Cr Positive Free Cash Flow 8/10
March 2015 ₹60 Cr ₹27 Cr Positive Free Cash Flow 7/10